NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-7.09%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.97B
AUM Growth
+$1.97B
Cap. Flow
+$21.4M
Cap. Flow %
1.09%
Top 10 Hldgs %
74.92%
Holding
37
New
6
Increased
2
Reduced
3
Closed
2

Top Buys

1
ARDX icon
Ardelyx
ARDX
$94.1M
2
HIVE
AEROHIVE NETWORKS, INC.
HIVE
$39M
3
ROKA
Sorrento Tech, Inc. Common Stock
ROKA
$32.4M
4
CRCM
CARE.COM, INC.
CRCM
$26.6M
5
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$19.9M

Top Sells

1
FIO
FUSION-IO INC COM
FIO
$79.5M
2
ITMN
INTERMUNE INC
ITMN
$59.2M
3
EPZM
Epizyme, Inc
EPZM
$35.1M
4
CVT
CVENT, INC.
CVT
$25.4M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$6.98M

Sector Composition

1 Healthcare 48.22%
2 Communication Services 19.23%
3 Technology 18.17%
4 Consumer Discretionary 1.35%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences, Inc.
ALIM
$12.2M 0.62%
150,376
– –
GYRE icon
27
Gyre Therapeutics
GYRE
$734M
$11.6M 0.59%
5,799
– –
ECOM
28
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$9.13M 0.46%
556,692
– –
AUPH icon
29
Aurinia Pharmaceuticals
AUPH
$1.58B
$8.15M 0.41%
+2,546,843
New +$8.15M
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$710M
$6.29M 0.32%
324,315
– –
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.24M 0.22%
173,896
– –
EXEL icon
32
Exelixis
EXEL
$9.95B
$3.38M 0.17%
2,207,000
– –
ARQL
33
DELISTED
Arqule Inc
ARQL
$2.82M 0.14%
2,520,316
– –
AGRX
34
DELISTED
Agile Therapeutics, Inc
AGRX
$218K 0.01%
15
+4
+36% +$58.1K
NURO
35
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$103K 0.01%
22
– –
FIO
36
DELISTED
FUSION-IO INC COM
FIO
– –
-7,038,379
Closed -$79.5M
ITMN
37
DELISTED
INTERMUNE INC
ITMN
– –
-1,341,000
Closed -$59.2M
1
2